Author Details

Tom Porter

Tom Porter

Former Executive-in-Residence, Sam Zell & Robert H. Lurie Institute for Entrepreneurial Studies; University of Michigan's Ross School of Business

Tom Porter is General Partner for Trillium Ventures in Ann Arbor, Michigan and has a broad range of experience in founding, managing and advising successful technology growth companies. He was formerly Executive in Residence at the Zell-Lurie Institute for Entrepreneurial Studies at the Ross School of Business at the University of Michigan. While there he founded and directed the Frankel Fund (now the Zell Lurie Fund), a student-run, seed stage investment fund. He also co-founded EDF Ventures, an early stage venture capital firm, where he led the health care practice for 16 years, as well as co-founded five health care companies.  He has also held board positions in numerous early stage companies and currently serves as an advisor to four venture capital funds. Porter holds an MBA degree from the University of Michigan where he currently serves as a Director of the National Advisory Board for the Office of Technology Transfer. He taught at U-M’s Ross School of Business for 20 years.

Author Products

Filter Results

Advanced Search

Tom Porter has 3 products available, viewing 1-3.

Raising Money? Better Have an Investment Thesis and Be Able to Pitch It!
“Raising Money?” is an exercise for developing an effective investment thesis for raising capital. When raising capital, entrepreneurs or companies at any stage of growth need to tailor their proposal,…
Publication Date: 12/18/2013 Product ID: 1-429-368
$3.95
Genesis BioSystems: The Board Weighs In on Product Development Setbacks
Genesis BioSystems is a venture-backed start-up that has developed a potentially revolutionary alternative to in-vitro fertilization. Before bringing the product to market, Genesis must achieve several key milestones, including the…
Publication Date: 05/24/2012 Product ID: 1-429-144
$3.95
How Much and From Whom? An Exercise in Seed-Stage Financing
The founders of start-up biotech company Chiral Intermediates have an important decision to make. How much money to raise? When? And from what kinds of funding sources? This exercise walks…
Publication Date: 03/29/2011 Product ID: 1-429-165
$3.95